Barney Graham, a former scientist at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), was thrilled when Pfizer announced encouraging results from an experimental vaccine that could protect against a major childhood killer. In a press release, the company said immunizing pregnant women with its vaccine against respiratory syncytial virus (RSV) protected their babies from severe […]
Pfizer
Pfizer set to test new COVID-19 pill on long-covid patients
Plans for the first test of whether Pfizer’s COVID-19 pill known as Paxlovid can alleviate Long Covid were unveiled last week, as organizers said they expect to begin recruiting 1700 volunteers in January 2023. Patient groups and researchers have long sought such a trial to study whether suppressing the SARS-CoV-2 coronavirus can reduce Long COVID’s debilitating […]
Pfizer quadruples price of COVID-19 vaccines
Pfizer’s plan to quadruple US prices for its COVID-19 vaccine next year is beyond Wall Street’s expectations and will spur its revenue for years despite weaker than anticipated demand for the new booster shot so far, analysts said. www.reuters.com/business/healthcare-pharmaceuticals/pfizer-covid-vaccine-price-hike-seen-giving-revenue-boost-years-2022-10-21/? The drugmaker, which developed and sells the vaccine with Germany’s BioNTech (22UAy.DE), said on Thursday evening […]
Moderna sues rival Pfizer/BioNTech over patent violation of mRNA Covid vaccine
The vaccine manufacturer Moderna has sued pharma major Pfizer and BioNTech, claiming that its rivals’ Covid-19 shot violates its patents protecting its ground-breaking technology www.nytimes.com/2022/08/26/business/moderna-covid-vaccine-lawsuit.html Moderna said in a statement that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 that covered its mRNA technology. Moderna, which is based in Cambridge, Mass., sued […]
Paxlovid appears to reduce the risk of dying from COVID-19 by 79% in those over 65
The antiviral drug Paxlovid appears to reduce the risk of dying from COVID-19 by 79% and decrease hospitalizations by 73% in at-risk patients aged 65 and older, according to a new study published in The New England Journal of Medicine. The pill, which is a combination of the drugs nirmatrelvir and ritonavir, received FDA emergency use authorization in […]
Global heating will make you ill — just not how you think it will
Coming as it does at a time when COVID-19 resolutely refuses to pack up and go away, the 2021 United Nations Climate Change Conference (COP26) in Glasgow this November will likely discuss not only international climate action but the impact of climate on health issues as well. As the Lancet Countdown 2020 Report explained, no continent, country, or community is immune from […]
Pfizer vaccine talks ongoing with expert group
An expert government panel is in talks regarding the BioNTech / Pfizer vaccine, Union Health Minister Mankush Mandaviya told the Lok Sabha on Friday. The Minister said “an expert group of the Indian government is still in talks with Pfizer over COVID vaccine supply.” United States State Department spokesperson Ned Price has announced that the […]
Pfizer/BioNTech vaccine: Less effective against Delta variant?
The Pfizer/BioNTech vaccine against COVID-19 has registered a lower level of efficacy in preventing the Delta variant first identified in India, according to new data from Israel. Effectiveness of the vaccine has dropped to 64 percent in preventing infection as the Delta variant spreads in Israel, now accounting for ninety percent of the country’s cases. […]
Pfizer vaccine on the cusp of securing Indian approval, CEO says
The Pfizer vaccine against COVID-19 is on the verge of securing approval for use in India. This is according to the drugmaker’s chief executive officer Albert Bourla who, speaking at a virtual event, said they were in the “final stages” of receiving the nod and said “I hope very soon we will finalise an agreement […]
Pfizer withdraws approval application in India
Drugmaker Pfizer has rescinded its emergency use authorisation application for its vaccine candidate against COVID-19. However, it intends to resubmit. The pharmaceutical giant sought emergency use authorisation for its vaccine in India last year but “has decided to withdraw its application at this time” according to a company spokesperson. Pfizer’s vaccine showed promising results in […]